Glück Conviction Score™ ⓘ
ADMA
ADMA BIOLOGICS, INC.
Effektiv: Stark
Mittel
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
57,0
64 neu, 141 erhöht, -2117542K $ netto
Aktivist
11,7
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bärisch | 10 % | 9.24 | -11.2 % vs SMA50 | |
| Kurs vs SMA200 | Bärisch | 15 % | 14.50 | -43.4 % vs SMA200 | |
| SMA-Cross | Bärisch | 10 % | DEATH | vor 73 Tagen @ 15.57 | |
| EMA20 vs EMA50 | Bärisch | 5 % | 8.33 | EMA50: 9.52 | |
| MACD-Histogramm | Bullisch | 10 % | 0.144 | Bullisch | |
| RSI(14) | Neutral | 10 % | 43.0 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 52.4 | Neutral | |
| ADX(14)+DI | Bärisch | 10 % | 27.0 | +DI: 24.2 / −DI: 25.5 | |
| Z-Score(60) | Neutral | 5 % | -0.83 | In Range | |
| 52W-Position | Bärisch | 5 % | 4.4 % | Hoch 21.60 / Tief 7.60 | |
| Bollinger(20,2σ) | Neutral | 5 % | 56.0 % | Upper 8.68 / Mid 8.15 / Lower 7.61 | |
| LinReg-Slope(60) | Bärisch | 10 % | -0.0623 | R²=0.47 / annualisiert -165.0 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-05-27 | Grossman Jerrold B | Director | Open Market Purchase | 6.400 | 7,91 | 50.624,00 | +16,2% | |
| 2026-05-12 | Grossman Jerrold B | Director | Open Market Purchase | 12.500 | 8,01 | 100.125,00 | +32,0% | |
| 2026-05-11 | Grossman Jerrold B | Director | Open Market Purchase | 12.500 | 8,01 | 100.125,00 | +32,0% | |
| 2026-03-16 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -6.000 | 15,16 | -90.960,00 | -29,0% | |
| 2026-03-16 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -15.000 | 15,16 | -227.400,00 | -72,6% | |
| 2026-03-09 | Kestenberg-Messina Kaitlin M. | Officer, COO and SVP, Compliance | Open Market Sale | -10.096 | 15,63 | -157.800,48 | -50,4% | |
| 2026-03-06 | ELMS STEVE | Director | Open Market Purchase | 7.000 | 15,39 | 107.730,00 | +34,4% | |
| 2026-03-05 | ELMS STEVE | Director | Open Market Purchase | 7.000 | 15,67 | 109.690,00 | +35,0% | |
| 2026-02-17 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -15.000 | 16,08 | -241.200,00 | -77,0% | |
| 2026-02-17 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -6.000 | 16,08 | -96.480,00 | -30,8% | |
| 2025-12-15 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -15.000 | 19,79 | -296.850,00 | -94,7% | |
| 2025-12-15 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -6.000 | 19,79 | -118.740,00 | -37,9% | |
| 2025-11-19 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -15.000 | 16,00 | -240.000,00 | -76,6% | |
| 2025-11-19 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -6.000 | 16,00 | -96.000,00 | -30,6% | |
| 2025-10-24 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -15.000 | 16,00 | -240.000,00 | -76,6% | |
| 2025-10-24 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -6.000 | 16,00 | -96.000,00 | -30,6% | |
| 2025-09-15 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -15.000 | 16,13 | -241.950,00 | -77,2% | |
| 2025-09-15 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -6.000 | 16,13 | -96.780,00 | -30,9% | |
| 2025-08-15 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -6.000 | 16,88 | -101.280,00 | -32,3% | |
| 2025-08-15 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -15.000 | 16,88 | -253.200,00 | -80,8% | |
| 2025-07-15 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -15.000 | 18,66 | -279.900,00 | -89,3% | |
| 2025-07-15 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -6.000 | 18,66 | -111.960,00 | -35,7% | |
| 2025-06-16 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -6.000 | 20,81 | -124.860,00 | -39,8% | |
| 2025-06-16 | Grossman Adam S | Director, Officer, President and CEO | Open Market Sale | -15.000 | 20,81 | -312.150,00 | -99,6% | |
| 2025-06-16 | ELMS STEVE | Director | Open Market Sale | -194.749 | 20,24 | -3.941.719,76 | -1258,0% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 20.854.669 | 0 | 20.854.669 | 380.389.162 | Neu | +100,0% | |
| BlackRock, Inc. | 36.830.774 | 36.333.325 | 497.449 | 331.845.274 | Aufgestockt | +1,4% | |
| Sachem Head Capital Management LP | 11.375.000 | 0 | 11.375.000 | 207.480.000 | Neu | +100,0% | |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 6.992.907 | 0 | 6.992.907 | 127.550.624 | Neu | +100,0% | |
| STATE STREET CORP | 14.084.205 | 13.597.259 | 486.946 | 126.898.687 | Aufgestockt | +3,6% | |
| Capital Research Global Investors | 11.191.116 | 6.637.472 | 4.553.644 | 100.831.955 | Aufgestockt | +68,6% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 10.306.871 | 0 | 10.306.871 | 92.864.908 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 6.247.242 | 1.894.470 | 4.352.772 | 56.287.651 | Aufgestockt | +229,8% | |
| Nuveen, LLC | 6.098.225 | 5.926.390 | 171.835 | 54.945.008 | Aufgestockt | +2,9% | |
| GEODE CAPITAL MANAGEMENT, LLC | 5.824.116 | 5.830.941 | -6.825 | 52.484.178 | Reduziert | -0,1% | |
| Caligan Partners LP | 5.056.511 | 3.012.508 | 2.044.003 | 45.559.164 | Aufgestockt | +67,9% | |
| DIMENSIONAL FUND ADVISORS LP | 5.005.481 | 4.835.638 | 169.843 | 45.101.264 | Aufgestockt | +3,5% | |
| AMERICAN CENTURY COMPANIES INC | 4.789.011 | 5.198.379 | -409.368 | 43.148.996 | Reduziert | -7,9% | |
| AWM Investment Company, Inc. | 2.200.000 | 0 | 2.200.000 | 40.128.000 | Neu | +100,0% | |
| Invesco Ltd. | 4.119.577 | 11.785.202 | -7.665.625 | 37.117.389 | Reduziert | -65,0% | |
| BANK OF AMERICA CORP /DE/ | 3.997.675 | 1.926.337 | 2.071.338 | 36.019.052 | Aufgestockt | +107,5% | |
| JANE STREET GROUP, LLC | 3.667.643 | 798.124 | 2.869.519 | 33.045.464 | Aufgestockt | +359,5% | |
| MILLENNIUM MANAGEMENT LLC | 3.434.449 | 769.671 | 2.664.778 | 30.944.385 | Aufgestockt | +346,2% | |
| Caption Management, LLC | 3.333.700 | 362.500 | 2.971.200 | 30.036.637 | Aufgestockt | +819,6% | |
| Point72 Asset Management, L.P. | 3.309.657 | 441.079 | 2.868.578 | 29.820.010 | Aufgestockt | +650,4% | |
| B Group, Inc. | 3.207.542 | 2.457.542 | 750.000 | 28.899.953 | Aufgestockt | +30,5% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 3.152.304 | 2.950.455 | 201.849 | 28.402.259 | Aufgestockt | +6,8% | |
| GOLDMAN SACHS GROUP INC | 2.803.530 | 1.069.525 | 1.734.005 | 25.259.806 | Aufgestockt | +162,1% | |
| PFM Health Sciences, LP | 1.270.894 | 0 | 1.270.894 | 23.181.107 | Neu | +100,0% | |
| MORGAN STANLEY | 2.434.379 | 1.948.373 | 486.006 | 21.933.757 | Aufgestockt | +24,9% | |
| FRANKLIN RESOURCES INC | 2.344.899 | 2.793.856 | -448.957 | 21.127.540 | Reduziert | -16,1% | |
| Ranger Investment Management, L.P. | 2.283.810 | 2.300.905 | -17.095 | 20.577.128 | Reduziert | -0,7% | |
| NORTHERN TRUST CORP | 2.277.312 | 2.266.890 | 10.422 | 20.518.581 | Aufgestockt | +0,5% | |
| UBS Group AG | 2.150.276 | 4.569.343 | -2.419.067 | 19.373.987 | Reduziert | -52,9% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.095.772 | 2.257.708 | -161.936 | 18.882.906 | Reduziert | -7,2% | |
| TWO SIGMA INVESTMENTS, LP | 2.092.133 | 504.174 | 1.587.959 | 18.850.118 | Aufgestockt | +315,0% | |
| Aberdeen Group plc | 963.949 | 0 | 963.949 | 17.582.430 | Neu | +100,0% | |
| BNP PARIBAS FINANCIAL MARKETS | 1.905.472 | 1.141.106 | 764.366 | 17.168.303 | Aufgestockt | +67,0% | |
| Stonepine Capital Management, LLC | 1.890.000 | 740.000 | 1.150.000 | 17.028.900 | Aufgestockt | +155,4% | |
| TUDOR INVESTMENT CORP ET AL | 1.874.089 | 236.306 | 1.637.783 | 16.885.542 | Aufgestockt | +693,1% | |
| Qube Research & Technologies Ltd | 1.829.670 | 0 | 1.829.670 | 16.485.327 | Neu | +100,0% | |
| Rubric Capital Management LP | 1.809.408 | 0 | 1.809.408 | 16.302.766 | Neu | +100,0% | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 890.861 | 0 | 890.861 | 16.249.305 | Neu | +100,0% | |
| MetLife Investment Management, LLC | 1.738.062 | 1.381.588 | 356.474 | 15.659.939 | Aufgestockt | +25,8% | |
| FEDERATED HERMES, INC. | 1.701.315 | 189.659 | 1.511.656 | 15.328.848 | Aufgestockt | +797,0% | |
| Fundsmith LLP | 1.649.493 | 2.102.054 | -452.561 | 14.861.932 | Reduziert | -21,5% | |
| PRINCIPAL FINANCIAL GROUP INC | 1.390.313 | 1.403.300 | -12.987 | 12.526.721 | Reduziert | -0,9% | |
| Holocene Advisors, LP | 629.314 | 0 | 629.314 | 11.478.687 | Neu | +100,0% | |
| RENAISSANCE TECHNOLOGIES LLC | 1.262.634 | 1.532.621 | -269.987 | 11.376.332 | Reduziert | -17,6% | |
| Trexquant Investment LP | 1.144.841 | 370.820 | 774.021 | 10.315.017 | Aufgestockt | +208,7% | |
| Catalio Capital Management, LP | 564.461 | 0 | 564.461 | 10.295.769 | Neu | +100,0% | |
| Y-Intercept (Hong Kong) Ltd | 1.075.422 | 66.874 | 1.008.548 | 9.689.552 | Aufgestockt | +1508,1% | |
| BOOTHBAY FUND MANAGEMENT, LLC | 1.054.383 | 788.352 | 266.031 | 9.499.991 | Aufgestockt | +33,7% | |
| DEUTSCHE BANK AG\ | 930.962 | 1.822.996 | -892.034 | 8.387.967 | Reduziert | -48,9% | |
| ROYAL BANK OF CANADA | 929.326 | 169.342 | 759.984 | 8.373.000 | Aufgestockt | +448,8% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 36.830.774 | 36.333.325 | +1,4% | 331.845.274 | 18,10 |
| STATE STREET CORP | 14.084.205 | 13.597.259 | +3,6% | 126.898.687 | 6,92 |
| Capital Research Global Investors | 11.191.116 | 6.637.472 | +68,6% | 100.831.955 | 5,50 |
| VANGUARD CAPITAL MANAGEMENT LLC | 10.306.871 | 0 | +100,0% | 92.864.908 | 5,06 |
| CITADEL ADVISORS LLC | 6.247.242 | 1.894.470 | +229,8% | 56.287.651 | 3,07 |
| Nuveen, LLC | 6.098.225 | 5.926.390 | +2,9% | 54.945.008 | 3,00 |
| GEODE CAPITAL MANAGEMENT, LLC | 5.824.116 | 5.830.941 | -0,1% | 52.484.178 | 2,86 |
| Caligan Partners LP | 5.056.511 | 3.012.508 | +67,9% | 45.559.164 | 2,48 |
| DIMENSIONAL FUND ADVISORS LP | 5.005.481 | 4.835.638 | +3,5% | 45.101.264 | 2,46 |
| AMERICAN CENTURY COMPANIES INC | 4.789.011 | 5.198.379 | -7,9% | 43.148.996 | 2,35 |
| Invesco Ltd. | 4.119.577 | 11.785.202 | -65,0% | 37.117.389 | 2,02 |
| BANK OF AMERICA CORP /DE/ | 3.997.675 | 1.926.337 | +107,5% | 36.019.052 | 1,96 |
| JANE STREET GROUP, LLC | 3.667.643 | 798.124 | +359,5% | 33.045.464 | 1,80 |
| MILLENNIUM MANAGEMENT LLC | 3.434.449 | 769.671 | +346,2% | 30.944.385 | 1,69 |
| Caption Management, LLC | 3.333.700 | 362.500 | +819,6% | 30.036.637 | 1,64 |
| Point72 Asset Management, L.P. | 3.309.657 | 441.079 | +650,4% | 29.820.010 | 1,63 |
| B Group, Inc. | 3.207.542 | 2.457.542 | +30,5% | 28.899.953 | 1,58 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 3.152.304 | 2.950.455 | +6,8% | 28.402.259 | 1,55 |
| GOLDMAN SACHS GROUP INC | 2.803.530 | 1.069.525 | +162,1% | 25.259.806 | 1,38 |
| MORGAN STANLEY | 2.434.379 | 1.948.373 | +24,9% | 21.933.757 | 1,20 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 354 | 232,0 | 2.031 |
| 31.12.2025 | ✓ | 356 | 227,8 | 4.008 |
| 30.09.2025 | ✓ | 366 | 229,5 | 3.294 |
| 30.06.2025 | ✓ | 372 | 217,7 | 3.713 |
| 31.03.2025 | ✓ | 349 | 222,9 | 4.208 |
| 31.12.2024 | ✓ | 317 | 220,2 | 3.642 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| Fundsmith LLP | 2.102.054 | 38.341.465 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 1.550.857 | 28.288.000 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1.023.250 | 18.664.080 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 890.861 | 16.249.305 |
| Holocene Advisors, LP | 629.314 | 11.478.687 |
| FINDELL CAPITAL MANAGEMENT LLC | 300.000 | 5.472.000 |
| Brevan Howard Capital Management LP | 246.772 | 4.501.121 |
| TUDOR INVESTMENT CORP ET AL | 236.306 | 4.310.221 |
| Parkman Healthcare Partners LLC | 200.000 | 3.648.000 |
| Motley Fool Asset Management LLC | 107.589 | 1.962.423 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 3.936.419 | 3.838.158 | +3906.1 % | 71.819.965 |
| Capital Research Global Investors | 6.637.472 | 3.383.559 | +104.0 % | 121.067.489 |
| UBS Group AG | 4.569.343 | 2.581.670 | +129.9 % | 83.344.816 |
| Sachem Head Capital Management LP | 11.375.000 | 2.415.000 | +27.0 % | 207.480.000 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 6.992.907 | 1.886.105 | +36.9 % | 127.550.624 |
| BNP PARIBAS FINANCIAL MARKETS | 1.141.106 | 1.091.241 | +2188.4 % | 20.813.773 |
| BANK OF AMERICA CORP /DE/ | 1.926.337 | 778.961 | +67.9 % | 35.136.387 |
| NEXT CENTURY GROWTH INVESTORS LLC | 1.100.773 | 705.217 | +178.3 % | 20.078.099 |
| BlackRock, Inc. | 36.333.325 | 701.611 | +2.0 % | 662.719.847 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2.950.455 | 558.362 | +23.3 % | 53.816.299 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| GOLDMAN SACHS GROUP INC | 1.069.525 | -1.841.282 | -63.3 % | 19.508.136 |
| CITADEL ADVISORS LLC | 1.894.470 | -1.367.892 | -41.9 % | 34.555.133 |
| RENAISSANCE TECHNOLOGIES LLC | 1.532.621 | -1.237.821 | -44.7 % | 27.955.007 |
| ROYAL BANK OF CANADA | 169.342 | -1.236.507 | -88.0 % | 3.089.000 |
| Allspring Global Investments Holdings, LLC | 490.144 | -1.057.995 | -68.3 % | 8.763.774 |
| PICTON MAHONEY ASSET MANAGEMENT | 230.816 | -913.222 | -79.8 % | 4.210.084 |
| Point72 Asset Management, L.P. | 441.079 | -880.937 | -66.6 % | 8.045.281 |
| COMERICA BANK | 52.102 | -720.532 | -93.3 % | 950.329 |
| Invesco Ltd. | 11.785.202 | -720.276 | -5.8 % | 214.962.084 |
| CITIGROUP INC | 102.986 | -468.073 | -82.0 % | 1.878.465 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 29.04.2026 | Vanguard Capital Management | Passiv (13G) | 5,08 % | 12.110.153 | Neu | |
| 26.03.2026 | The Vanguard Group | Passiv (13G/A) | Ausstieg | 0 | -8,94 pp | |
| 12.02.2026 | Invesco Ltd. | Passiv (13G/A) | 5,00 % | 11.785.202 | -0,40 pp | |
| 11.08.2025 | STATE STREET CORPORATION | Passiv (13G) | 5,10 % | 12.078.505 | +0,30 pp | |
| 29.07.2025 | The Vanguard Group | Passiv (13G/A) | 8,94 % | 21.363.715 | +1,17 pp | |
| 13.05.2025 | STATE STREET CORPORATION | Passiv (13G) | 4,80 % | 11.440.778 | -0,80 pp | |
| 09.05.2025 | Invesco Ltd. | Passiv (13G) | 5,40 % | 12.866.904 | +0,60 pp | |
| 30.04.2025 | BlackRock, Inc. | Passiv (13G/A) | 15,10 % | 35.907.601 | Neu | |
| 07.02.2025 | Invesco Ltd. | Passiv (13G/A) | 4,80 % | 11.296.255 | -0,70 pp | |
| 12.11.2024 | The Vanguard Group | Passiv (13G/A) | 7,77 % | 18.118.494 | 0,00 pp | |
| 08.11.2024 | Invesco Ltd. | Passiv (13G) | 5,50 % | 12.793.559 | Neu | |
| 04.11.2024 | The Vanguard Group | Passiv (13G) | 7,77 % | 18.118.494 | +2,06 pp | |
| 17.10.2024 | STATE STREET CORPORATION | Passiv (13G) | 5,60 % | 13.004.993 | Neu | |
| 07.10.2024 | . BlackRock, Inc. | Passiv (13G/A) | 16,40 % | 38.269.434 | +8,50 pp | |
| 23.09.2024 | Millennium Management LLC | Passiv (13G) | 0,60 % | 1.374.038 | -2,60 pp | |
| 23.09.2024 | Millennium Group Management LLC | Passiv (13G) | 0,60 % | 1.374.038 | -2,60 pp | |
| 23.09.2024 | Israel A. Englander | Passiv (13G) | 0,60 % | 1.374.038 | -2,60 pp | |
| 11.03.2024 | TIAA-CREF Investment Management, LLC | Passiv (13G/A) | 1,69 % | 3.855.058 | 0,00 pp | |
| 11.03.2024 | Teachers Advisors, LLC | Passiv (13G/A) | 0,98 % | 2.230.535 | 0,00 pp | |
| 11.03.2024 | Nuveen Asset Management, LLC | Passiv (13G/A) | 2,17 % | 4.955.411 | 0,00 pp | |
| 11.03.2024 | Nuveen Asset Management, LLC | Passiv (13G/A) | 2,17 % | 4.955.411 | 0,00 pp | |
| 11.03.2024 | Teachers Advisors, LLC | Passiv (13G/A) | 0,98 % | 2.230.535 | 0,00 pp | |
| 11.03.2024 | TIAA-CREF Investment Management, LLC | Passiv (13G/A) | 1,69 % | 3.855.058 | 0,00 pp | |
| 11.03.2024 | Teachers Advisors, LLC | Passiv (13G/A) | 0,98 % | 2.230.535 | 0,00 pp | |
| 11.03.2024 | Nuveen Asset Management, LLC | Passiv (13G/A) | 2,17 % | 4.955.411 | -0,07 pp | |
| 11.03.2024 | TIAA-CREF Investment Management, LLC | Passiv (13G/A) | 1,69 % | 3.855.058 | -0,11 pp | |
| 14.02.2024 | Perceptive Life Sciences Master Fund, Ltd. | Passiv (13G/A) | 2,80 % | 6.433.369 | Neu | |
| 14.02.2024 | Joseph Edelman | Passiv (13G/A) | 2,80 % | 6.433.369 | Neu | |
| 14.02.2024 | Perceptive Advisors LLC | Passiv (13G/A) | 2,80 % | 6.433.369 | Neu | |
| 14.02.2024 | TIAA-CREF Investment Management, LLC | Passiv (13G) | 1,80 % | 4.077.569 | 0,00 pp | |
| 14.02.2024 | Teachers Advisors, LLC | Passiv (13G) | 0,98 % | 2.215.363 | 0,00 pp | |
| 14.02.2024 | Nuveen Asset Management, LLC | Passiv (13G) | 2,24 % | 5.062.545 | 0,00 pp | |
| 14.02.2024 | Teachers Advisors, LLC | Passiv (13G) | 0,98 % | 2.215.363 | 0,00 pp | |
| 14.02.2024 | TIAA-CREF Investment Management, LLC | Passiv (13G) | 1,80 % | 4.077.569 | 0,00 pp | |
| 14.02.2024 | Nuveen Asset Management, LLC | Passiv (13G) | 2,24 % | 5.062.545 | 0,00 pp | |
| 14.02.2024 | Teachers Advisors, LLC | Passiv (13G) | 0,98 % | 2.215.363 | +0,03 pp | |
| 14.02.2024 | TIAA-CREF Investment Management, LLC | Passiv (13G) | 1,80 % | 4.077.569 | +1,19 pp | |
| 14.02.2024 | Nuveen Asset Management, LLC | Passiv (13G) | 2,24 % | 5.062.545 | -0,24 pp | |
| 13.02.2024 | The Vanguard Group | Passiv (13G) | 5,71 % | 12.891.875 | Neu | |
| 26.01.2024 | . BlackRock, Inc. | Passiv (13G/A) | 7,90 % | 17.917.745 | +1,00 pp |
Stammdaten
ADMA Biologics, Inc., ein biopharmaceutisches Unternehmen, befasst sich mit der Entwicklung, Herstellung und Vermarktung spezialisierter plasmaabgeleiteter Biologika zur Behandlung von Immundefizienzen und Infektionskrankheiten in den Vereinigten Staaten und international. Das Unternehmen bietet BIVIGAM, ein intravenöses Immunglobulin-Präparat (IVIG) zur Behandlung primärer humoraler Immundefizienz (PI); ASCENIV, ein IVIG-Produkt zur Behandlung von PI; sowie Nabi-HB zur Behandlung von akuter Blutkontamination mit Hepatitis-B-Oberflächenantigen und weiteren aufgeführten Hepatitis-B-Expositionen an. Das Unternehmen entwickelt ferner eine Pipeline plasmaabgeleiteter Therapeutika, einschließlich Produktkandidaten für Methoden der Behandlung und Prävention von Pneumococcus-Infektionen mit Immunglobulin. Darüber hinaus betreibt das Unternehmen Ausgangsspenderplasma-Sammelstellen. Das Unternehmen vermarktet seine Produkte über unabhängige Vertreiber, Vertriebsvertreter, Spezialitäten-Apotheken und weitere Anbieter an alternativen Verkaufsorten. ADMA Biologics, Inc. wurde 2004 gegründet und hat seinen Sitz in Ramsey, New Jersey.
Unternehmen & Branche
| Name | ADMA BIOLOGICS, INC. |
|---|---|
| Ticker | ADMA |
| CIK | 0001368514 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2836 · Biological Products, (No Diagnostic Substances) |
Wertpapier & Kennzahlen
| CUSIP | 000899104 |
|---|---|
| ISIN | US0008991046 |
| Typ | Common Stock |
| Marktkapitalisierung | 2,01 Mrd. USD |
| KGV (P/E) | 14,12 |
| Beta | 0,81 |
Bewertung
| KBV (P/B) | 4,22 vs. 1,96 (2021) ▲ |
|---|---|
| KUV (P/S) | 3,95 vs. 3,41 (2021) ▲ |
| EV/EBITDA | 10,1 |
| FCF-Rendite | 1,4 % vs. -45,6 % (2021) ▲ |
| Buyback-Rendite | 1,6 % |
Qualität & Bilanz
| Bruttomarge | 57,4 % vs. 1,4 % (2021) ▲ |
|---|---|
| Operative Marge | 37,5 % vs. -72,1 % (2021) ▲ |
| Nettomarge | 28,8 % vs. -88,5 % (2021) ▲ |
| ROIC | 26,4 % vs. -48,0 % (2021) ▲ |
| Nettoverschuldung/EBITDA | 0,0 |
| Zinsdeckungsgrad | 26,9 vs. -4,5 (2021) ▲ |
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|---|---|
| Bewertung | ||||||
| KBV (P/B) | 1,96 | 5,66 | 7,56 | 11,63 | 9,09 | |
| KUV (P/S) | 3,41 | 5,59 | 3,96 | 9,52 | 8,50 | |
| EV/EBITDA | – | – | 33,6 | 27,5 | 21,7 | |
| FCF-Rendite | -45,6 % | -8,5 % | 0,4 % | 2,7 % | 0,6 % | |
| Buyback-Rendite | – | – | 0,0 % | 0,0 % | 0,7 % | |
| Qualität & Bilanz | ||||||
| Bruttomarge | 1,4 % | 22,9 % | 34,4 % | 51,5 % | 57,4 % | |
| Operative Marge | -72,1 % | -25,5 % | 8,4 % | 32,6 % | 37,5 % | |
| Nettomarge | -88,5 % | -42,8 % | -10,9 % | 46,4 % | 28,8 % | |
| ROIC | -48,0 % | -40,3 % | -19,3 % | 45,8 % | 26,4 % | |
| Nettoverschuldung/EBITDA | – | – | -1,4 | -0,1 | 0,0 | |
| Zinsdeckungsgrad | -4,5 | -2,0 | 0,9 | 10,0 | 26,9 | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | 114.493.000 | 45.328.000 | 0,19 | 665.184.000 | 390.325.000 |
| 2025-12-31 | 10-K | 510.173.000 | 146.930.000 | 0,60 | 624.242.000 | 477.320.000 |
| 2025-09-30 | 10-Q | 134.224.000 | 36.428.000 | 0,15 | 568.687.000 | 431.186.000 |
| 2025-06-30 | 10-Q | 121.984.000 | 34.219.000 | 0,14 | 558.380.000 | 398.325.000 |
| 2025-03-31 | 10-Q | 114.802.000 | 26.904.000 | 0,11 | 510.569.000 | 373.419.000 |
| 2024-12-31 | 10-K | 426.454.000 | 197.673.000 | 0,81 | 488.678.000 | 349.018.000 |
| 2024-09-30 | 10-Q | 119.839.000 | 35.909.000 | 0,15 | 390.618.000 | 231.890.000 |
| 2024-06-30 | 10-Q | 107.191.000 | 32.062.000 | 0,13 | 376.399.000 | 188.269.000 |
| 2024-03-31 | 10-Q | 81.875.000 | 17.806.000 | 0,08 | 350.875.000 | 153.706.000 |
| 2023-12-31 | 10-K | 258.215.000 | -28.239.000 | -0,13 | 329.182.000 | 135.206.000 |
| 2023-09-30 | 10-Q | 67.275.000 | 2.565.000 | 0,01 | 348.997.000 | 151.437.000 |
| 2023-06-30 | 10-Q | 60.123.000 | -6.371.000 | -0,03 | 343.027.000 | 146.762.000 |
| 2023-03-31 | 10-Q | 56.914.000 | -6.789.000 | -0,03 | 340.788.000 | 145.655.000 |
| 2022-12-31 | 10-K | 154.080.000 | -65.904.000 | -0,33 | 348.461.000 | 151.974.000 |
| 2022-09-30 | 10-Q | 41.090.137 | -14.899.504 | -0,08 | 300.557.570 | 100.384.536 |
| 2022-06-30 | 10-Q | 33.905.007 | -13.764.906 | -0,07 | 296.932.329 | 114.400.527 |
| 2022-03-31 | 10-Q | 29.103.093 | -25.007.857 | -0,13 | 308.032.492 | 126.933.065 |
| 2021-12-31 | 10-K | 80.943.000 | -71.648.000 | -0,51 | 276.253.000 | 141.173.000 |
| 2021-09-30 | 10-Q | 20.680.550 | -17.712.954 | -0,13 | 238.640.406 | 102.780.167 |
| 2021-06-30 | 10-Q | 17.830.590 | -18.905.303 | -0,15 | 232.813.792 | 111.593.532 |
Umsatz nach Segmenten & Regionen ⓘ
Geschäftssegmente
| Segment | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| ADMABio Manufacturing Segment | 493,1 Mio. | 415,9 Mio. | 249,9 Mio. | – | – | 96,7 % | +18,6% | |
| Plasma Collection Centers Segment | 17,0 Mio. | 10,5 Mio. | 8,3 Mio. | – | – | 3,3 % | +62,1% | |
| Product | – | – | – | 153,9 Mio. | 80,8 Mio. | – | – | |
| License And Service | – | – | – | 142.834 | 142.834 | – | – |
Regionen
| Region | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| US | 504,1 Mio. | 410,1 Mio. | 244,9 Mio. | 146,4 Mio. | 70,6 Mio. | 98,8 % | +22,9% | |
| Non Us | 6,1 Mio. | 16,3 Mio. | 13,3 Mio. | 7,7 Mio. | 10,3 Mio. | 1,2 % | -62,6% |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 06.05.2026 | 114,5 Mio. USD | 0,19 |
| Q3 2025 | 30.09.2025 | 05.11.2025 | 134,2 Mio. USD | 0,15 |
| Q2 2025 | 30.06.2025 | 05.11.2025 | 122,0 Mio. USD | 0,14 |
| Q1 2025 | 31.03.2025 | 06.05.2026 | 114,8 Mio. USD | 0,11 |
| Q3 2024 | 30.09.2024 | 05.11.2025 | 119,8 Mio. USD | 0,15 |
| Q2 2024 | 30.06.2024 | 05.11.2025 | 107,2 Mio. USD | 0,13 |
| Q1 2024 | 31.03.2024 | 05.11.2025 | 81,9 Mio. USD | 0,08 |
| Q3 2023 | 30.09.2023 | 07.11.2024 | 67,3 Mio. USD | 0,01 |
| Q2 2023 | 30.06.2023 | 07.11.2024 | 60,1 Mio. USD | -0,03 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 06.05.2026 | 10-Q | 31.03.2026 | 36 Tage | SEC » |
| 25.02.2026 | 10-K | 31.12.2025 | 56 Tage | SEC » |
| 05.11.2025 | 10-Q | 30.09.2025 | 36 Tage | SEC » |
| 06.08.2025 | 10-Q | 30.06.2025 | 37 Tage | SEC » |
| 07.05.2025 | 10-Q | 31.03.2025 | 37 Tage | SEC » |
| 18.03.2025 | 10-K | 31.12.2024 | 77 Tage | SEC » |
| 07.11.2024 | 10-Q | 30.09.2024 | 38 Tage | SEC » |
| 08.08.2024 | 10-Q | 30.06.2024 | 39 Tage | SEC » |
| 09.05.2024 | 10-Q | 31.03.2024 | 39 Tage | SEC » |
| 28.02.2024 | 10-K | 31.12.2023 | 59 Tage | SEC » |
| 08.11.2023 | 10-Q | 30.09.2023 | 39 Tage | SEC » |
| 09.08.2023 | 10-Q | 30.06.2023 | 40 Tage | SEC » |
| 10.05.2023 | 10-Q | 31.03.2023 | 40 Tage | SEC » |
| 23.03.2023 | 10-K | 31.12.2022 | 82 Tage | SEC » |
| 09.11.2022 | 10-Q | 30.09.2022 | 40 Tage | SEC » |
| 10.08.2022 | 10-Q | 30.06.2022 | 41 Tage | SEC » |
| 11.05.2022 | 10-Q | 31.03.2022 | 41 Tage | SEC » |
| 24.03.2022 | 10-K | 31.12.2021 | 83 Tage | SEC » |
| 10.11.2021 | 10-Q | 30.09.2021 | 41 Tage | SEC » |
| 11.08.2021 | 10-Q | 30.06.2021 | 42 Tage | SEC » |
| 12.05.2021 | 10-Q | 31.03.2021 | 42 Tage | SEC » |
| 25.03.2021 | 10-K | 31.12.2020 | 84 Tage | SEC » |
| 05.11.2020 | 10-Q | 30.09.2020 | 36 Tage | SEC » |
| 05.08.2020 | 10-Q | 30.06.2020 | 36 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 25.02.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 99.1.* Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 21.02.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 02.01.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 21.11.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 26.07.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 02.04.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 28.02.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 02.10.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 10.03.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 21.06.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 09.03.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 18.10.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 01.10.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 14.06.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 02.03.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 28.04.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 03.04.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 05.03.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-05-13 | 294 | 8,41 | 2.473 |
| 2026-05-12 | 1.324 | 7,88 | 10.433 |
| 2026-05-11 | 500 | 8,17 | 4.085 |
| 2026-05-04 | 500 | 10,52 | 5.260 |
| 2026-04-28 | 3.237 | 10,93 | 35.380 |
| 2026-04-23 | 600 | 10,95 | 6.570 |
| 2026-04-20 | 15.481 | 11,01 | 170.446 |
| 2026-04-08 | 1.638 | 9,26 | 15.168 |
| 2026-04-07 | 316 | 9,28 | 2.932 |
| 2026-03-26 | 4.400 | 9,63 | 42.372 |
| 2026-03-17 | 38 | 15,84 | 602 |
| 2026-03-16 | 36.705 | 15,15 | 556.081 |
| 2026-02-27 | 265 | 15,18 | 4.023 |
| 2026-02-23 | 7.752 | 16,10 | 124.807 |
| 2026-02-12 | 30.169 | 16,28 | 491.151 |
| 2026-02-09 | 397 | 16,43 | 6.523 |
| 2026-02-04 | 2.256 | 17,52 | 39.525 |
| 2026-01-15 | 86.476 | 18,28 | 1.580.781 |
| 2026-01-13 | 74.547 | 17,93 | 1.336.628 |
| 2025-12-22 | 625 | 19,58 | 12.237 |
| 2025-12-18 | 7.480 | 18,83 | 140.848 |
| 2025-12-17 | 536 | 19,17 | 10.275 |